GluCorp Pvt. Ltd. – Trademark Portfolio

Entity Type: 16

GluCorp Pvt. Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include GLUCORP ORGANIC PEOPLE ORGANIC WORLD. The owner is based in Karachi City, Sindh.

Area Karachi

plot 42, Sector 28 Korangi Industrial

Karachi City, Sindh 75500 , PK

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

GluCorp Pvt. Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does GluCorp Pvt. Ltd. have?

GluCorp Pvt. Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does GluCorp Pvt. Ltd. file in?

GluCorp Pvt. Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are GluCorp Pvt. Ltd.'s most well-known trademarks?

GluCorp Pvt. Ltd.'s registered trademark portfolio includes well-known marks such as GLUCORP ORGANIC PEOPLE ORGANIC WORLD. These are among 1 currently registered trademark in the portfolio.

What is GluCorp Pvt. Ltd.'s trademark registration success rate?

GluCorp Pvt. Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.